BioCell Labs initiates product development
Biocell to deliver Hemp-based nutraceutical supplements
Abattis Bioceuticals Corp. (www.abattis.com), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, biosimilar compounds, patented equipment and consulting services to medicinal markets in North America, would like to announce that through its wholly owned subsidiary, Biocell Labs, Inc., a marketing agenda to deliver Hemp-based nutraceutical supplements to the licensed health care provider marketplace.
Brazos Minshew, president of BioCell Labs, Inc., explains: 'There are four major pathways for nutraceutical distribution. The top tier is always the professional marketplace, where nutraceutical sales representatives call on licensed healthcare providers and educate them on the medical application of herbal medicines. These products are always governed by government regulatory agencies, such as Natural Health Products Canada. The physician or other licensed provider then makes the determination as to whether or not the nutraceutical will benefit the patient.'
Minshew explains that other nutraceutical distribution channels include Direct Response advertising (including internet sales), Direct Sales associations and the Retail marketplace, including brick-and-mortar vitamin stores, pharmacies or dispensaries.
'Our nutraceutical products are really potent, powerful extracts of classic herbal medicines. For example, Actaea racemosa is known to reduce nerve pain and the pain associated with osteo- and rheumatoid arthritis, as well as anxiety. As such, these formulas may be appropriately applied to improve the health and wellbeing of people suffering from a host of physical and emotional imbalances," Minshew says.
This announcement follows an agreement reached with Empirical Labs of Ft Collins, Colorado, for the exclusive use of patented liposome technology. 'Liposomes are related to transport molecules that dramatically improves nutrient absorption into the cells of humans and animals. This has the effect of making the herbal remedies even more powerful and effective,' states Emek Blair, PhD.
Next steps for BioCell Labs, Inc. and Abattis BioCeuticals Corp. is to license these nutraceuticals through Health Canada's nutraceutical application process, then to craft legally compliant literature to be used in training the licensed healthcare providers, to partner with a distribution channel and train their sales team, to craft marketing literature and finally to produce the products themselves.
These products will be available to the public through licensed healthcare providers in Canada and the USA. Product launches are scheduled early in Q2 2015.
